UCL Discovery
UCL home » Library Services » Electronic resources » UCL Discovery

British Society for Immunology and United Kingdom Primary Immunodeficiency Network (UKPIN) consensus guideline for the management of immunoglobulin replacement therapy

Grigoriadou, S; Clubbe, R; Garcez, T; Huissoon, A; Grosse-Kreul, D; Jolles, S; Henderson, K; ... Bethune, C; + view all (2022) British Society for Immunology and United Kingdom Primary Immunodeficiency Network (UKPIN) consensus guideline for the management of immunoglobulin replacement therapy. Clinical and Experimental Immunology , 210 (1) pp. 1-13. 10.1093/cei/uxac070. Green open access

[thumbnail of British Society for Immunology and United Kingdom Primary Immunodeficiency Network (UKPIN) consensus guideline for the manag.pdf]
Preview
Text
British Society for Immunology and United Kingdom Primary Immunodeficiency Network (UKPIN) consensus guideline for the manag.pdf - Other

Download (222kB) | Preview

Abstract

Currently, there is no guideline to support the use of immunoglobulin replacement therapy (IgRT) in primary and secondary immunodeficiency disorders in UK. The UK Primary Immunodeficiency Network (UK-PIN) and the British Society of Immunology (BSI) joined forces to address this need. Given the paucity of evidence, a modified Delphi approach was used covering statements for the initiation, monitoring, discontinuation of IgRT as well as home therapy programme. A group of six consultant immunologists and three nurse specialists created the statements, reviewed responses and feedback and agreed on final recommendations. This guideline includes 22 statements for initiation, 22 statements for monitoring, 11 statement for home therapy, and 19 statements for discontinuation of IgRT. Further areas of research are proposed to improve future delivery of care.

Type: Article
Title: British Society for Immunology and United Kingdom Primary Immunodeficiency Network (UKPIN) consensus guideline for the management of immunoglobulin replacement therapy
Location: England
Open access status: An open access version is available from UCL Discovery
DOI: 10.1093/cei/uxac070
Publisher version: https://doi.org/10.1093/cei/uxac070
Language: English
Additional information: © The Author(s) 2022. Published by Oxford University Press on behalf of the British Society for Immunology. This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs licence (https://creativecommons.org/licenses/by-nc-nd/4.0/), which permits non-commercial reproduction and distribution of the work, in any medium, provided the original work is not altered or transformed in any way, and that the work is properly cited. For commercial re-use, please contact journals.permissions@oup.com
Keywords: Human, immunodeficiency disorders, immunoglobulin, antibodies
UCL classification: UCL
UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences
UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Medical Sciences
UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Medical Sciences > Div of Infection and Immunity
URI: https://discovery.ucl.ac.uk/id/eprint/10159866
Downloads since deposit
39Downloads
Download activity - last month
Download activity - last 12 months
Downloads by country - last 12 months

Archive Staff Only

View Item View Item